6-64307084-TGAGAGAGAGAGA-TGAGAGAGAGA

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_001142800.2(EYS):​c.6079-4_6079-3delTC variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.544 in 860,580 control chromosomes in the GnomAD database, including 81,349 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.68 ( 34426 hom., cov: 0)
Exomes 𝑓: 0.52 ( 46923 hom. )

Consequence

EYS
NM_001142800.2 splice_region, intron

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.762

Publications

8 publications found
Variant links:
Genes affected
EYS (HGNC:21555): (eyes shut homolog) The product of this gene contains multiple epidermal growth factor (EGF)-like and LamG domains. The protein is expressed in the photoreceptor layer of the retina, and the gene is mutated in autosomal recessive retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
EYS Gene-Disease associations (from GenCC):
  • EYS-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • retinitis pigmentosa
    Inheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • retinitis pigmentosa 25
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 6-64307084-TGA-T is Benign according to our data. Variant chr6-64307084-TGA-T is described in ClinVar as Benign. ClinVar VariationId is 196616.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.7 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001142800.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EYS
NM_001142800.2
MANE Select
c.6079-4_6079-3delTC
splice_region intron
N/ANP_001136272.1
EYS
NM_001292009.2
c.6079-4_6079-3delTC
splice_region intron
N/ANP_001278938.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EYS
ENST00000503581.6
TSL:5 MANE Select
c.6079-4_6079-3delTC
splice_region intron
N/AENSP00000424243.1
EYS
ENST00000370621.7
TSL:1
c.6079-4_6079-3delTC
splice_region intron
N/AENSP00000359655.3

Frequencies

GnomAD3 genomes
AF:
0.680
AC:
101866
AN:
149726
Hom.:
34406
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.673
Gnomad AMI
AF:
0.493
Gnomad AMR
AF:
0.673
Gnomad ASJ
AF:
0.722
Gnomad EAS
AF:
0.487
Gnomad SAS
AF:
0.707
Gnomad FIN
AF:
0.643
Gnomad MID
AF:
0.627
Gnomad NFE
AF:
0.706
Gnomad OTH
AF:
0.668
GnomAD2 exomes
AF:
0.551
AC:
51515
AN:
93566
AF XY:
0.546
show subpopulations
Gnomad AFR exome
AF:
0.565
Gnomad AMR exome
AF:
0.553
Gnomad ASJ exome
AF:
0.542
Gnomad EAS exome
AF:
0.503
Gnomad FIN exome
AF:
0.573
Gnomad NFE exome
AF:
0.557
Gnomad OTH exome
AF:
0.548
GnomAD4 exome
AF:
0.515
AC:
366350
AN:
710750
Hom.:
46923
AF XY:
0.517
AC XY:
191570
AN XY:
370368
show subpopulations
African (AFR)
AF:
0.515
AC:
8945
AN:
17376
American (AMR)
AF:
0.506
AC:
13610
AN:
26882
Ashkenazi Jewish (ASJ)
AF:
0.528
AC:
10066
AN:
19080
East Asian (EAS)
AF:
0.474
AC:
13416
AN:
28278
South Asian (SAS)
AF:
0.519
AC:
29973
AN:
57746
European-Finnish (FIN)
AF:
0.532
AC:
22719
AN:
42686
Middle Eastern (MID)
AF:
0.580
AC:
2363
AN:
4074
European-Non Finnish (NFE)
AF:
0.515
AC:
247515
AN:
480314
Other (OTH)
AF:
0.517
AC:
17743
AN:
34314
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.611
Heterozygous variant carriers
0
8539
17079
25618
34158
42697
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4802
9604
14406
19208
24010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.680
AC:
101929
AN:
149830
Hom.:
34426
Cov.:
0
AF XY:
0.676
AC XY:
49371
AN XY:
73020
show subpopulations
African (AFR)
AF:
0.673
AC:
27562
AN:
40958
American (AMR)
AF:
0.672
AC:
10091
AN:
15010
Ashkenazi Jewish (ASJ)
AF:
0.722
AC:
2497
AN:
3458
East Asian (EAS)
AF:
0.488
AC:
2479
AN:
5084
South Asian (SAS)
AF:
0.707
AC:
3343
AN:
4730
European-Finnish (FIN)
AF:
0.643
AC:
6526
AN:
10150
Middle Eastern (MID)
AF:
0.637
AC:
186
AN:
292
European-Non Finnish (NFE)
AF:
0.706
AC:
47414
AN:
67176
Other (OTH)
AF:
0.670
AC:
1382
AN:
2062
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1603
3205
4808
6410
8013
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
806
1612
2418
3224
4030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.573
Hom.:
2265
Bravo
AF:
0.677

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Dec 03, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jun 12, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:2
Apr 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Retinitis Pigmentosa, Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Retinitis pigmentosa Benign:1
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.76
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35395170; hg19: chr6-65016977; COSMIC: COSV65484750; API